Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$10.54 USD
-0.17 (-1.59%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $10.52 -0.02 (-0.19%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -0.06 |
EPS Last Quarter | -0.11 |
Last EPS Surprise | -83.33% |
ABR | 1.40 |
Earnings ESP
|
-62.16% |
---|---|
Current Year | 0.01 |
Next Year | 0.34 |
EPS (TTM) | -0.51 |
P/E (F1) | 1,071.00 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 111.02M | 124.65M | 528.28M | 659.59M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 114.40M | 126.07M | 547.40M | 689.27M |
Low Estimate | 109.20M | 123.30M | 511.09M | 628.50M |
Year ago Sales | 86.27M | 94.50M | 399.36M | 528.28M |
Year over Year Growth Est. | 28.69% | 31.91% | 32.28% | 24.86% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.06 | -0.02 | 0.01 | 0.34 |
# of Estimates | 6 | 4 | 7 | 6 |
Most Recent Consensus | -0.07 | -0.04 | -0.07 | 0.26 |
High Estimate | -0.03 | -0.01 | 0.18 | 0.60 |
Low Estimate | -0.10 | -0.04 | -0.15 | 0.17 |
Year ago EPS | -0.18 | -0.15 | -0.51 | 0.01 |
Year over Year Growth Est. | 66.67% | 86.67% | 101.96% | 3,333.30% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 4 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 0 | 5 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.06 | -0.02 | 0.01 | 0.34 |
7 Days Ago | -0.06 | -0.02 | 0.01 | 0.34 |
30 Days Ago | -0.06 | -0.02 | 0.02 | 0.35 |
60 Days Ago | -0.07 | -0.04 | 0.07 | 0.42 |
90 Days Ago | -0.07 | -0.04 | 0.06 | 0.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | -0.02 | -0.15 | 0.27 |
Zacks Consensus Estimate | -0.06 | -0.02 | 0.01 | 0.34 |
Earnings ESP | -62.16% | 0.00% | -1,600.00% | -21.36% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.11 | -0.07 | -0.15 | -0.18 | NA |
Estimate | -0.06 | -0.08 | -0.12 | -0.13 | NA |
Difference | -0.05 | 0.01 | -0.03 | -0.05 | -0.03 |
Surprise | -83.33% | 12.50% | -25.00% | -38.46% | -33.57% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more